a distinct primary cutaneous B-cell lymphoma, but exhibiting an excellent prognosis. This type of lymphoma can therefore be treated with nonaggressive therapeutic modalities such as orthovolt radiotherapy, antibiotics, or steroids. The advantage of such an approach is to provide the diagnosis according to current classifications of lymphomas, and in addition, to include essential information about the biologic behavior. These data are crucial for the clinician involved in counseling and treatment of the patient and simplifies the management of patients, even in cases of rare and unusual CL.
The three categories and the comprised clinicopathologic entities according to the WHO classification for tumours of haemotopoietic (2) are outlined in Table 2.
Was this article helpful?